Cross-species and interassay comparisons of phytoestrogen action.
This paper compiles animal and human data on the biologic effects and exposure levels of phytoestrogens in order to identify areas of research in which direct species comparisons can be made. In vitro and in vivo assays of phytoestrogen action and potency are reviewed and compared to actions, dose-response relationships, and estimates of exposure in human subjects. Binding studies show that the isoflavonoid phytoestrogens are high-affinity ligands for estrogen receptors (ERs), especially ER beta, but have lower potency in whole-cell assays, perhaps because of interactions with binding proteins. Many other enzymatic actions require concentrations higher than those normally seen in plasma. In vivo data show that phytoestrogens have a wide range of biologic effects at doses and plasma concentrations seen with normal human diets. Significant in vivoresponses have been observed in animal and human tests for bone, breast, ovary, pituitary, vasculature, prostate, and serum lipids. The doses reported to be biologically active in humans (0.4--10 mg/kg body weight/day) are lower than the doses generally reported to be active in rodents (10--100 mg/kg body weight/day), although some studies have reported rodent responses at lower doses. However, available estimates of bioavailability and peak plasma levels in rodents and humans are more similar. Steroidogenesis and the hypothalamic-pituitary-gonadal axis appear to be important loci of phytoestrogen actions, but these inferences must be tentative because good dose-response data are not available for many end points. The similarity of reported proliferative and antiproliferative doses illustrates the need for fuller examination of dose-response relationships and multiple end points in assessing phytoestrogen actions.
Department of Anthropology, Emory University, Atlanta, Georgia 03022, USA. antpw@emory.edu
P L
PL
Whitten
H B
HB
Patisaul
D000818:Animals; D001681:Biological Assay / Q000379:methods; D015519:Bone Density / Q000187:drug effects; D001940:Breast / Q000187:drug effects / Q000473:pathology; D002455:Cell Division / Q000187:drug effects; D004032:Diet; D004305:Dose-Response Relationship, Drug; D004703:Endocrine System / Q000187:drug effects*; D004967:Estrogens / Q000819:agonists*; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects; D010937:Plant Growth Regulators / Q000494:pharmacology*; D014566:Urogenital System / Q000187:drug effects / Q000473:pathology
D004967:Estrogens; D010937:Plant Growth Regulators